Valuation: Linc AB

Market Cap 4.07B 421M 368M 340M 315M 597M 39.95B 607M 1.58B 19.72B 1.58B 1.55B 68.16B P/E 2024
3.84x
P/E 2025 -10.1x
Enterprise Value 3.79B 392M 343M 316M 293M 556M 37.17B 565M 1.47B 18.34B 1.47B 1.44B 63.4B EV / Sales 2024
3.45x
EV / Sales 2025 -9.06x
Free-Float
36.64%
Yield 2024 *
-
Yield 2025 -
1 day-1.21%
1 week-1.55%
Current month-1.55%
1 month-3.05%
3 months-2.37%
6 months+4.79%
Current year+0.43%
1 week 69.6
Extreme 69.6
73.7
1 month 66.6
Extreme 66.6
73.7
Current year 58.9
Extreme 58.9
78.1
1 year 58.9
Extreme 58.9
83.6
3 years 52.2
Extreme 52.2
103.4
5 years 43.8
Extreme 43.8
109.9
10 years 43.8
Extreme 43.8
118.2
Manager TitleAgeSince
Chief Executive Officer 52 2019-12-31
Director of Finance/CFO 44 2019-12-31
Director TitleAgeSince
Chairman 73 1990-12-31
Director/Board Member 52 2019-12-31
Director/Board Member 60 2019-12-31
Date Insider Type Main position Quantity % Market Cap.
04-27Buy

Director

20,000 0.0345%
04-27Buy

Director

3,000 0.0052%
04-24Buy

Director

9,000 0.0155%
Change 5-day change 1-year change 3-year change Capi.($)
-1.21%-1.55%-10.37%+15.13% 421M
0.00%+1.36%+10.37%-2.61% 154M
Average -0.60%-0.90%-0.00%+6.26% 287.42M
Weighted average by Cap. -0.89%-1.01%-4.82%+10.38%

Financials

2024 2025
Net sales 1.29B 134M 117M 108M 99.81M 189M 12.67B 193M 502M 6.25B 501M 490M 21.62B -414M -42.81M -37.46M -34.53M -32M -60.75M -4.06B -61.73M -161M -2.01B -161M -157M -6.93B
Net income 1.3B 135M 118M 109M 101M 191M 12.77B 194M 506M 6.3B 505M 494M 21.79B -400M -41.33M -36.16M -33.33M -30.89M -58.64M -3.92B -59.59M -155M -1.94B -155M -152M -6.69B
Net Debt -550M -56.84M -49.74M -45.84M -42.49M -80.66M -5.39B -81.96M -214M -2.66B -213M -209M -9.2B -284M -29.37M -25.7M -23.68M -21.95M -41.67M -2.79B -42.34M -110M -1.38B -110M -108M -4.75B
Logo Linc AB
Linc AB is a Sweden-based investment company. Linc invests in product-oriented companies within the Nordic Life Science industry - primarily in pharmaceutical and medical technology companies. The investments are made in both private and public companies and in research and operational companies. Typically, investments in drug development take place in an earlier phase compared to investments in medical technology. Linc Invest is an active and long-term owner with a wide industrial network to support the portfolio companies. The Company works together with the management, founders and board to realize the inherent potential that exists in the investment, have ambitious plans for further development and expansion and actively participate in the nomination committee work.
Employees
2
Date Price Change Volume
26-07-08 SEK 70.00 -0.43% 16,613
26-07-07 SEK 70.30 -2.09% 21,491
26-07-06 SEK 71.80 -2.31% 24,181
26-07-03 SEK 73.50 +1.80% 18,441
26-07-02 SEK 72.20 +0.98% 34,244
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
70.30SEK
Average target price
71.00SEK
Spread / Average Target
+1.00%
  1. Stock Market
  2. Stocks
  3. LINC Stock